# An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.

> **NCT07182214** · — · RECRUITING · sponsor: **Pharus Taiwan, Inc.** · enrollment: 1340 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **OTHER:** Collect blood sample

## Key facts

- **NCT ID:** NCT07182214
- **Lead sponsor:** Pharus Taiwan, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-05
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 1340 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07182214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07182214, "An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07182214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*